Health outcome research – Evidence-Based Decision Making for Pricing and Reimbursement

The international postgraduate ULG Health Outcome Research jointly organized by VSCR and SFU took place from 15.11-18.11.18 at the Sigmund Freud University Vienna.

There were postgraduate students from 10 different countries (Austria, Germany, Czech Republic, Latvia, United Arab Emirates, Nepal, Iran, Norway, Serbia and Poland).

The professors and lecturers came from Austria, Switzerland, Germany, Belgium, Hungary.

The language of instruction was English.

The key note lecture on how to define innovation was given by Suerie Moon, Harvard University, Boston, MPA, PhD, followed by a public panel discussion with national and international stakeholders.

The repetition of this module Evidence-Based Decision Making for Pricing and Reimbursement will take place from 27 to 29 May 2019 and later in October 2019.

Mag. Margarete Schreiner-Karner, Manager VSCR Prof. Heinrich Klech, CEO VSCR

Prof. Heinrich Klech, CEO VSCR & Prof. Lieven Annemans, University Ghent

Mag. Margarete Schreiner-Karner, Manager VSCR & Prof. Lieven Annemans, University Ghent

VSCR-SFU University Course Health Outcome Research

Participants from Germany, Austria, Serbia, Czech Republic, Norway, Iran, Latvia, Nepal, Poland, Dubai

View our photogallery from Module 1 »

Opening Key Note Lecture and Panel Discussion

Prof. Alfred Pritz, Rector SFU

Key note lecture: HOW TO DEFINE INNOVATION?

Suerie Moon, MPA, PhD, Research Director at the Harvard Global Health Institute and The Graduate Institute in Geneva

RESPONSE FROM INDUSTRY AND LESSONS LEARNED

Dr. Jürgen Raths, CEO Cordeé Consulting, Geneva

Panel Discussion – Value and Price of Innovation in Pharmaceuticals and Devices

left to right – Dr. Vladimir Kopernicky, Vice President, International Medical Affairs, Eli Lilly
DrDr. Wolfgang Wein, General Manager Merck Austria
Dr. Sylvia Nanz, Medical Director Pfizer Austria
Priv.-Doz. Dr. phil. Claudia Wild, Director of Ludwig Boltzmann Institut, HTA
Univ. Prof. Dr. Heinrich Kelch, CEO VSCR
Dr. Anna Bucsics, Former Department Head, Department of Pharmaceutical Affairs, Federation of Austrian Social Insurance Institutions
Dr. Martin Gleitsmann, Head of Department of Social Policy and Health, Austrian Federal Economic Chamber
Univ.-Prof. Dr. Ernst Agneter, MBA, Executive Board of Association of the Austrian Pharmaceutical Industry, Chairman of the Pharmig working group Health Economics & Reimbursement